Zydus receives final and tentative approval from USFDA for Tofacitinib Tablets
Tofacitinib Tablets, 5 mg and 10 mg had annual sales of US $900 million in the United States (IQVIA MAT December 2022)
Tofacitinib Tablets, 5 mg and 10 mg had annual sales of US $900 million in the United States (IQVIA MAT December 2022)
The audit is a pre-approval inspection for three products filed from the facility
According to IQVIA sales data for the 12-month period ending January 2023, the Compazine Tablets, 5 mg and 10 mg market achieved annual sales of approximately US $26.9 million
Rocuronium Bromide Injection had an annual sale of approximately US $53 million in the US (IQVIA MAT December 2022)
Cleocin Hydrochloride Capsules market achieved annual sales of approximately US $33.6 million
The facility has been set up to manufacture tuberculosis testing cartridges
ALPLA is expanding its presence in the global market for pharmaceutical packaging by establishing a joint venture with Inden Pharma
The agreement is for USFDA approved Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets
The business serves the healthcare and laboratory sectors on the west coast of the United States.
Thiamine Hydrochloride Injection is effective in the treatment of vitamin B1 deficiency (beriberi)
Subscribe To Our Newsletter & Stay Updated